Mr Alastair Mobley BSc, MRes

Mr Alastair Mobley

Department of Cardiovascular Sciences
Trial Team Manager

Contact details

Address
Floor 2, Institute of Translational Medicine
Heritage Building
Mindelsohn Way
Birmingham
B15 2TH

Alastair is a Trial Team Manager and PhD student based in the Department of Cardiovascular Sciences at University of Birmingham. Alastair leads the Dare2THINK and CardAIc teams, which bring together clinicians and data scientists to deliver data-enabled clinical trials in both Cardiology and Primary care. The team’s portfolio includes the UK's first fully data-enabled randomised clinical trial, DaRe2THINK (data-driven remote randomised trial in primary care). The Horizon Europe and UKRI-funded HYPERMARKER project (AI and -omics guided precision treatment), and work with the West Midlands NHS SDE (data-enabled long-term follow-up of RATE-AF participants). Alastair's further role as the clinical studies lead for the Cities@Heart public-private initiative will help deliver pilots of public health interventions to address urban CVD health inequalities across European cities.

Alastair’s academic work focuses on the mechanisms linking atrial fibrillation, cardiovascular risk factors and cognitive decline, and how retinal imaging might provide a window into cerebral vascular health.

Qualifications

  • MRes Biomedical Research, University of Birmingham, 2015
  • BSc Medical Biochemistry, Swansea University, 2014

Other activities

Publications

Recent publications

Article

Huemer, J, Stuart, KV, Zhou, Y, Williamson, DJ, Woodward-Court, P, Mobley, A, Chandratheva, A, Berger, F, Aung, N, Peterson, S, UK Biobank Eye and Vision Consortium, Khawaja, AP, Petzold, A, Rahi, J, Denniston, AK, Kotecha, D, Keane, PA, Patel, PJ & Wagner, SK 2026, 'Atrial fibrillation and retinal imaging-based oculomics: A cross-sectional and longitudinal analysis of two large cohorts', PLOS Digital Health, vol. 5, no. 9, e0001661. https://doi.org/10.1371/journal.pdig.0001661

Zhang, Y, Liu, B, Bunting, KV, Brind, D, Thorley, A, Karwath, A, Lu, W, Zhou, D, Wang, X, Mobley, AR, Tica, O, Gkoutos, GV, Kotecha, D & Duan, J 2024, 'Development of automated neural network prediction for echocardiographic left ventricular ejection fraction', Frontiers in Medicine, vol. 11, 1354070. https://doi.org/10.3389/fmed.2024.1354070

Champsi, A, Mobley, A, Subramanian, A, Nirantharakumar, K, Wang, X, Shukla, D, Bunting, K, Molgaard, I, Dwight, J, Casado Arroyo, R, Crijns, HJGM, Guasti, L, Lettino, M, Lumbers, RT, Maesen, B, Rienstra, M, Svennberg, E, Tica, O, Traykov, V, Tzeis, S, van Gelder, I & Kotecha, D 2024, 'Gender and contemporary risk of adverse events in atrial fibrillation', European Heart Journal, vol. 45, no. 36, ehae539. https://doi.org/10.1093/eurheartj/ehae539

Mobley, AR, Subramanian, A, Champsi, A, Wang, X, Myles, P, McGreavy, P, Bunting, KV, Shukla, D, Nirantharakumar, K & Kotecha, D 2024, 'Thromboembolic events and vascular dementia in patients with atrial fibrillation and low apparent stroke risk', Nature Medicine. https://doi.org/10.1038/s41591-024-03049-9

Wang, X, Mobley, A, Tica, O, Okoth, K, Nirantharakumar, K, Shukla, D & Kotecha, D 2022, 'Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomised trial', European Heart Journal, vol. 3, no. 3, ztac046, pp. 426-436. https://doi.org/10.1093/ehjdh/ztac046

Karwath, A, Bunting, KV, Gill, SK, Tica, O, Pendleton, S, Aziz, F, Barsky, AD, Chernbumroong, S, Duan, J, Mobley, AR, Cardoso, VR, Slater, L, Williams, JA, Bruce, E, Wang, X, Flather, MD, Coats, AJS, Gkoutos, GV & Kotecha, D 2021, 'Redefining β-blocker response in heart failure patients with sinus rhythm and atrial fibrillation: a machine learning cluster analysis', The Lancet, vol. 2021, no. 10309, pp. 1-9. https://doi.org/10.1016/s0140-6736(21)01638-x

Abstract

Mobley, A, Wang, X, Champsi, A, Subramanian, A, Nirantharakumar, K & Kotecha, D 2023, '90 Thromboembolic events and vascular dementia in contemporary patients with atrial fibrillation and low apparent stroke risk', Heart, vol. 109, no. Suppl 3, pp. A99-A101. https://doi.org/10.1136/heartjnl-2023-bcs.90